- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06636084
Vertical and Horizontal Mandibular Ridge Augmentation Techniques
July 21, 2025 updated by: Hom-Lay Wang, DDS, MSD, Ph D, University of Michigan
Vertical and Horizontal Mandibular Ridge Augmentation Techniques: A Randomized Controlled Clinical Trial Comparing Customized CAD/CAM Titanium Mesh Versus Reinforced Perforated PTFE Mesh
The purpose of this study is to compare alveolar ridge augmentation outcomes of two types of membranes for vertical and horizontal mandibular ridge augmentation: Customized CAD/CAM Titanium Mesh versus Reinforced Perforated PTFE Mesh (RPM).
Study Overview
Status
Withdrawn
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan School of Dentistry
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Age ≥ 18 years
- Physical status according to the American Society of Anesthesiology (ASA) I or II, which includes patients who are systematically healthy or may suffer from mild to moderate, however well-controlled systemic diseases.
- Subjects having at least one free end saddle edentulous area of the posterior area of the mandible with moderate horizontal and vertical bone defects >≥3mm.
- Capacity to understand and accept the written conditions of the study.
Exclusion Criteria:
- Insufficient oral hygiene.
- Smoking habit of >10 cigarettes/day (self-reported).
- Abuse of alcohol or drugs.
- Pregnancy or individuals attempting to get pregnant (self-reported).
- Acute local or systemic infections.
- Uncontrolled diabetes or other metabolic disease.
- Severe hepatic or renal dysfunction.
- Autoimmune disorders.
- Patients who underwent radiotherapy in the last 5 years.
- Patients undergoing immunosuppressive therapy or who are immunocompromised.
- Any other contraindications for undergoing surgery.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Customized CAD/CAM Titanium Mesh
A customized CAD/CAM Titanium Mesh will be used to cover the bone graft
|
A composite graft composed of a 50:50 proportion of autogenous bone and a demineralized bone mineral will be positioned around the bony defect or placed in the membrane, depending on the group randomization.
The selected membrane will then be secured with screws to ensure a complete and stable coverage of the grafted area.
|
|
Active Comparator: Reinforced Perforated PTFE Mesh (RPM)
A Reinforced Perforated PTFE Mesh membrane will be used to cover the bone graft
|
A composite graft composed of a 50:50 proportion of autogenous bone and a demineralized bone mineral will be positioned around the bony defect or placed in the membrane, depending on the group randomization.
The selected membrane will then be secured with screws to ensure a complete and stable coverage of the grafted area.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ridge width changes in mm
Time Frame: 6 months
|
Radiographic changes of the ridge width based on cone-beam computed tomography (CBCT) scan measurements
|
6 months
|
|
Ridge height changes in mm
Time Frame: 6 months
|
Radiographic changes of the ridge width based on cone-beam computed tomography (CBCT) scan measurements
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Histological outcomes of the augmented bone
Time Frame: 6 months
|
In terms of the amount of newly formed vital bone, residual graft particles, and connective tissue (CT)/other non-mineralized tissue components as a percentage
|
6 months
|
|
The volumetric bone gain of the grafted area in mm3
Time Frame: 6 months
|
Radiographic changes of bone volume based on cone-beam computed tomography (CBCT) scan measurements
|
6 months
|
|
Rate of complications
Time Frame: 6 months
|
Percentage that had complications associated with each technique
|
6 months
|
|
Cost analysis
Time Frame: 6 months
|
Difference in cost-effectiveness in dollars
|
6 months
|
|
Change in the mucosal thickness in mm
Time Frame: 6 months
|
Change in the mucosal thickness due to the provided space from baseline to the surgical mesh removal using an ultrasound
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Hom-Lay Wang, DDS MSD PhD, Department of Periodontics and Oral Medicine, University of Michigan
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
December 1, 2025
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
June 1, 2027
Study Registration Dates
First Submitted
October 8, 2024
First Submitted That Met QC Criteria
October 8, 2024
First Posted (Actual)
October 10, 2024
Study Record Updates
Last Update Posted (Actual)
July 25, 2025
Last Update Submitted That Met QC Criteria
July 21, 2025
Last Verified
July 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- HUM00262750
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Horizontal Ridge Deficiency
-
Cairo UniversityNot yet recruitingHorizontal Ridge Deficiency | Horizontal Bone AugmentationEgypt
-
Mansoura UniversityCompleted
-
Ain Shams UniversityCompletedHorizontal Ridge DeficiencyEgypt
-
University of MichiganRecruiting
-
Cairo UniversityRecruiting
-
Cairo UniversityCompletedHorizontal Ridge DeficiencyEgypt
-
University of BaghdadCompleted
-
Saint-Joseph UniversityCompletedHorizontal Ridge DeficiencyLebanon
-
Cairo UniversityNot yet recruitingHorizontal Ridge Deficiency
-
Cairo UniversityNot yet recruitingHorizontal Ridge Deficiency
Clinical Trials on Guided bone regeneration (GBR)
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
Samer FarajCompleted
-
University of MichiganCompletedHorizontal Ridge DeficiencyUnited States
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
Cairo UniversityNot yet recruitingHorizontal Ridge Deficiency
-
University of ZagrebRecruitingPeriimplant Diseases | Dental Implant Failure | Dental Implant ComplicationsCroatia
-
Tanta UniversityActive, not recruitingDigital Guided Bone RegenerationEgypt
-
Universitat Internacional de CatalunyaNot yet recruitingDental Implant | Guided Bone Regeneration | Bone Atrophy | Submerged RegenerationSpain
-
BiomatlanteAtlanstatCompletedPeriodontal Bone Loss | Alveolar Bone Loss | Oral Bone Defect | Maxillofacial Bone DefectFrance
-
Saint-Joseph UniversityCompletedAlveolar Bone ResorptionLebanon